Skip to main content
Premium Trial:

Request an Annual Quote

DeCode's Q1 Revenue Falls 15 Percent as R&D Spending Slides and Loss Widens

NEW YORK (GenomeWeb News) — DeCode Genetics today said first-quarter revenues decreased 15 percent as R&D spending dropped 18 percent and losses rose 9 percent.
 
Total receipts for the three months ended March 31 fell to $8.6 million from $10.1 million year over year.
 
DeCode said it also had $11.6 million in deferred revenue at the close of the first quarter, which it will recognize over future periods.
 
R&D spending fell to $12.7 million from $15.5 million year over year.
 
The company said losses increased to $22.6 million from $20.7 million in the year-ago period.
 
CEO Kari Stefansson said the company said it plans to launch other diagnostic tests this year, and said the company’s results reflect its focus on “advancing and expanding our product pipeline, therapeutics and diagnostics.
 
DeCode said it had around $135.1 million in cash, cash equivalents, and investments as of March 31.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.